Engebretsen I, Bugge C, Støvring H, Husebye E, Sverre E, Dammen T, Halvorsen S, Munkhaugen J(2024) Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event Atherosclerosis, 393, 117550(in press) DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552
Sambola A, Halvorsen S, Adlam D, Hassager C, Price S, Rosano G, Schiele F, Holmvang L, de Riva M, Rakisheva A, Sulzgruber P, Swahn E(2024) Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy Eur Heart J Open, 4(2), oeae011 DOI 10.1093/ehjopen/oeae011, PubMed 38628674
van Diepen S, Halvorsen S, Menon V(2024) The REDUCE-AMI trial: An important step in cardiovascular drug de-prescription Eur Heart J Acute Cardiovasc Care(in press) DOI 10.1093/ehjacc/zuae049, PubMed 38608152